Search

DISCLOSURES: The study was funded by Bonafide Health, a company thatsells supplements to treat menopause symptoms, includingvaginal suppositories containing HLA. Latest News TOPLINE: Among women with genitourinary syndrome of menopause, 12weeks of treatment with vaginal suppositories containinghyaluronic acid (HLA) reduces vulvovaginal symptoms,according to trial results presented at the annualMenopause Meeting. [Extracted from the article]

The article offers information related to the 2023 annual conference of the American Society for Laser Medicine and Surgery held in Phoenix, Arizona. It informs that Macrene R. Alexiades, associate clinical professor of dermatology at Yale University, New Haven, Connecticut, presented her views on the use of lasers and energy-based devices for genitourinary indication.

Reports that Cardinals basketball coach Rick Pitino has missed one game while getting treatment for a urological ailment. Statistics of the team.Return of Pitino to coaching; Assessment of heatlh of Pitino.

Prostate cancer screening has substantially increased early detection of the disease, but a new study suggests that too few low-income men are being screened. The analysis, to be published in the February issue of The Journal of Urology, examined the medical records of 570 men who had received treatment for prostate cancer in a program for the poor and uninsured in California. It found that metastatic, or spreading, and other high-risk cancers were more common among them than in the general population. [ABSTRACT FROM PUBLISHER]

The urology rotation during my third year of medical school might best be described as a boys' club, often characterized by infighting, one-upmanship and sexual humor. It was a little off-putting to many students, but always entertaining. So imagine my surprise when a female medical student recently told me that she loved her urology rotation, in which she found the doctors to be especially humanistic and caring. A big part of the reason, she believed, was the growing presence of women among her teachers. It turns out that the field of urology is undergoing a gender transformation. [ABSTRACT FROM PUBLISHER]

The article reports on the plan being considered by GlaxoSmithKline to split off into a separate company some early-stage drugs. Andrew Witty says that Glaxo has discontinued its research in diseases related to the urinary and reproductive systems. Glaxo decided that urogenital disease is not an area which the company wants to put research dollars into, and shifted its scientists in that area to other products. Witty adds that Glaxo is not planning on spinning out a whole bunch of scientists as Astra-Zeneca did.